News Conference News TCT 2022 New Faces, New Formats, New Tech: What to Expect From TCT 2022 Shelley Wood September 07, 2022
News Conference News ESC 2022 GRACE 3.0: Women With NSTE ACS Get a Boost From Updated Score Caitlin E. Cox September 06, 2022
News Conference News ESC 2022 Routine Functional Testing Unnecessary After Stenting: POST-PCI Yael L. Maxwell September 06, 2022
News Conference News ESC 2022 ESC Revamps Guidelines on Ventricular Arrhythmias, Sudden Cardiac Death Todd Neale September 02, 2022
News Conference News ESC 2022 COVID-PACT: Full-Dose Anticoagulation Improves Outcomes in Critical COVID-19 Todd Neale September 01, 2022
News Conference News ESC 2022 New ESC/ERS Pulmonary Hypertension Guidelines Urge Precise Diagnosis, Early Treatment Shelley Wood September 01, 2022
News Conference News ESC 2022 Earlier Evolocumab Cut CVD, CV Mortality Over Longer Term: FOURIER-OLE Michael O'Riordan August 31, 2022
News Conference News ESC 2022 Only Very Small Risk of Muscle Symptoms With Statins: CTT Collaboration Michael O'Riordan August 29, 2022
News Conference News ESC 2022 Factor XIa Inhibitors Show Potential for Safer Anticoagulation After MI, Stroke Todd Neale August 28, 2022
News Conference News ESC 2022 DELIVER Results, Other Analyses Bolster SGLT2 Inhibitors Across HF Spectrum Todd Neale August 27, 2022
News Conference News ESC 2022 Old Drug Acetazolamide Offers New Tricks in Acute HF: ADVOR L.A. McKeown August 27, 2022
News Conference News ESC 2022 EchoNet AI Algorithm Beats Sonographers for Estimating LV Function Shelley Wood August 27, 2022
News Conference News ESC 2022 PCI No Better Than GDMT in Ischemic Cardiomyopathy: REVIVED-BCIS2 Michael O'Riordan August 27, 2022
News Conference News ESC 2022 Polypill Bests Usual Care in Patients With Recent MI: SECURE Michael O'Riordan August 26, 2022
News Conference News TVT 2022 Surgical Explant or Redo for TAVI Failures? Some Registry Insights Michael O'Riordan June 10, 2022
News Conference News TVT 2022 No Stroke Reduction With Embolic Protection in TAVI, Two Studies Suggest Michael O'Riordan June 09, 2022
News Conference News ESC Heart Failure 2022 Aficamten Safe, Effective for Up to 6 Months in Obstructive HCM: REDWOOD-HCM OLE Todd Neale May 31, 2022
News Conference News EAS 2022 Most Kids With FH Diagnosed by Cascade Screening, Albeit Late and Ineffectively Michael O'Riordan May 27, 2022
News Conference News SCAI 2022 Cath Labs Trying to Get Back on Track With Quality Measures, Documentation L.A. McKeown May 27, 2022
News Conference News EuroPCR 2022 Next-Generation Navitor Valve Shows Promise in High-risk TAVI Patients Yael L. Maxwell May 27, 2022